www.semnurpharma.com Open in urlscan Pro
67.205.31.16  Public Scan

Form analysis
1 forms found in the DOM

GET https://www.semnurpharma.com/

<form role="search" method="get" class="search-form" action="https://www.semnurpharma.com/">
  <label>
    <span class="screen-reader-text">Search for:</span>
    <input type="search" class="search-field" placeholder="Search …" value="" name="s">
  </label>
  <input type="submit" class="search-submit" value="Search">
</form>

Text Content

Sorrento Therapeutics Announces the Merger of Scilex and Semnur to Create a
Global Leader in Non-Opioid Pain Management".

click

Semnur
Pharmaceuticals™
Getting Back to Normal


MENU

Skip to content
 * About
 * Management
 * Chronic Back Pain
 * Clinical Study
 * News

 * Contact

Search
Search for:

Semnur Pharmaceuticals has started a Phase 3 study for the treatment of lumbar
radicular pain, commonly known as sciatica and has received fast track status
from the FDA for the novel injectable gel formulation (SP-102) in development.
Learn more

SP-102 is the first non-opioid novel injectable gel formulation in development
for the treatment of lumbar radicular pain/sciatica, containing no neurotoxic
preservatives, surfactants, solvents or particulates. Learn more

We are currently advancing a portfolio of non-opioid novel injectable drug
candidates that have the potential to provide better and more persistent
analgesia compared with existing therapies. Learn more


 * Contact
 * Privacy Policy
 * Terms of Use

©2022 Semnur Pharmaceuticals, Inc.
All rights reserved.
Semnur Pharmaceuticals, Inc. is being acquired by Scintilla Pharmaceuticals,
Inc.
Visit Scintilla Pharmaceuticals, Inc. Go To Semnur Pharmaceuticals